PHMMF (Pharma Mar) Other Operating Expense: $109.2 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHMMF Pharma Mar SA PHMMF
79 GF Score
Price $90.90
GF Value $89.67
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Other Operating Expense?

Pharma Mar PHMMF -3.64% 79 Other Operating Expense is $109.2 Mil as of Mar. 2026. GuruFocus rates PHMMF with a GF Score™ of 79/100 and a GF Value™ of $89.67 (Fairly Valued). The stock has 3 warning signs investors should review.

Pharma Mar's Other Operating Expense for the three months ended in Mar. 2026 was $2.8 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $109.2 Mil.

Pharma Mar's quarterly Other Operating Expense increased from Sep. 2025 ($1.7 Mil) to Dec. 2025 ($117.8 Mil) but then declined from Dec. 2025 ($117.8 Mil) to Mar. 2026 ($2.8 Mil).

Pharma Mar's annual Other Operating Expense increased from Dec. 2023 ($57.7 Mil) to Dec. 2024 ($59.7 Mil) and increased from Dec. 2024 ($59.7 Mil) to Dec. 2025 ($63.0 Mil).

Pharma Mar Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Other Operating Expense Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.32 12.27 57.75 59.67 62.97

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.85 -13.15 1.75 117.78 2.81
PHMMF
79GF Score
Pharma Mar SA PHMMF
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $109.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $109.2 Mil mean?
Pharma Mar (PHMMF) has a Other Operating Expense of $109.2 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Pharma Mar and its competitors.
Is Pharma Mar's Other Operating Expense too high?
Pharma Mar's current Other Operating Expense is $109.2 Mil. Overall, Pharma Mar has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Other Operating Expense compare to VRTX and REGN?
Pharma Mar's Other Operating Expense of $109.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Pharma Mar and its competitors. Pharma Mar's current Other Operating Expense is $109.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Based on GuruFocus' analysis, Pharma Mar (PHMMF) is currently considered Fairly Valued. The stock's GF Value™ is $89.67, compared to a current price of $90.90 — trading 1.4% above its estimated fair value. The current Other Operating Expense is $109.2 Mil. Pharma Mar's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Pharma Mar (PHMMF), the current Other Operating Expense is $109.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (PHMMF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be overvalued. The current stock price of $90.90 is trading 1.4% above its estimated GF Value™ of $89.67. GuruFocus considers Pharma Mar to be Fairly Valued.

Key valuation signals for PHMMF:

  • Other Operating Expense: $109.2 Mil
  • GF Value™: $89.67 vs. price of $90.90 (1.4% above fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the PHMMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
79GF Score

Get the complete analysis for PHMMF

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.90
Price
$89.67
GF Value